Fidelity Advisor Biotechnology C (FBTCX) - Health fund with $2.85 Billion in assets. The fund allocates 50.93% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.
The largest holding in the fund is ABBVIE INC at 14.83% of total assets. This is followed by AMGEN INC (2.58%) and Fidelity Securities Lending Cash Central Fund (3.59%).
| Name | Weight | Owned | Change |
|---|---|---|---|
| ABBVIE INC | 14.83% | - | - |
| AMGEN INC | 2.58% | - | - |
| Fidelity Securities Lending Cash Central Fund | 3.59% | - | - |
| REGENERON PHARMACEUTICALS INC | 6.90% | - | - |
| VERTEX PHARMACEUTICALS INC | 5.07% | - | - |
| ALNYLAM PHARMACEUTICALS INC | 5.52% | - | - |
| ARGENX SE SPONSORED ADR | 3.17% | - | - |
| ASCENDIS PHARMA AS SPON ADR | 4.49% | - | - |
| VAXCYTE INC | 2.18% | - | - |
| CYTOKINETICS INC | 2.60% | - | - |
| Fidelity Cash Central Fund | 2.05% | - | - |
| GILEAD SCIENCES INC | 5.42% | - | - |
| INSMED INC | 3.51% | - | - |
| NUVALENT INC-A | 2.29% | - | - |
| VIRIDIAN THERAPEUTICS INC | 3.15% | - | - |
| UNIQURE N.V. | 2.70% | - | - |
| COGENT BIOSCIENCES INC | 3.45% | - | - |
| BIOGEN INC | 2.92% | - | - |
| DIANTHUS THERAPEUTICS INC | 3.37% | - | - |
| SPYRE THERAPEUTICS INC | 3.33% | - | - |
| ASCENDIS PHARMA AS | 3.24% | - | - |